TY - JOUR
T1 - Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma
AU - Faggi, Fiorella
AU - Chiarelli, Nicola
AU - Colombi, Marina
AU - Mitola, Stefania
AU - Ronca, Roberto
AU - Madaro, Luca
AU - Bouche, Marina
AU - Poliani, Pietro L.
AU - Vezzoli, Marika
AU - Longhena, Francesca
AU - Monti, Eugenio
AU - Salani, Barbara
AU - Maggi, Davide
AU - Keller, Charles
AU - Fanzani, Alessandro
N1 - Funding Information:
This work was supported by the Fondazione Cariplo grant to E.M., Grant NEDD —Network Enabled Drug Design, Regione Lombardia to E.M. and University of Brescia research fund (ex 60%) to A.F., E.M. and S.M.
Publisher Copyright:
© 2015 USCAP, Inc.
PY - 2015/6/28
Y1 - 2015/6/28
N2 - Rhabdomyosarcoma (RMS) is a childhood soft tissue tumor with broad expression of markers that are typically found in skeletal muscle. Cavin-1 is a recently discovered protein actively cooperating with Caveolin-1 (Cav-1) in the morphogenesis of caveolae and whose role in cancer is drawing increasing attention. Using a combined in silico and in vitro analysis here we show that Cavin-1 is expressed in myogenic RMS tumors as well as in human and primary mouse RMS cultures, exhibiting a broad subcellular localization, ranging from nuclei and cytosol to plasma membrane. In particular, the coexpression and plasma membrane interaction between Cavin-1 and Cav-1 characterized the proliferation of human and mouse RMS cell cultures, while a downregulation of their expression levels was observed during the myogenic differentiation. Knockdown of Cavin-1 or Cav-1 in the human RD and RH30 cells led to impairment of cell proliferation and migration. Moreover, loss of Cavin-1 in RD cells impaired the anchorage-independent cell growth in soft agar. While the loss of Cavin-1 did not affect the Cav-1 protein levels in RMS cells, Cav-1 overexpression and knockdown triggered a rise or depletion of Cavin-1 protein levels in RD cells, respectively, in turn reflecting on increased or decreased cell proliferation, migration and anchorage-independent cell growth. Collectively, these data indicate that the interaction between Cavin-1 and Cav-1 underlies the cell growth and migration in myogenic tumors.
AB - Rhabdomyosarcoma (RMS) is a childhood soft tissue tumor with broad expression of markers that are typically found in skeletal muscle. Cavin-1 is a recently discovered protein actively cooperating with Caveolin-1 (Cav-1) in the morphogenesis of caveolae and whose role in cancer is drawing increasing attention. Using a combined in silico and in vitro analysis here we show that Cavin-1 is expressed in myogenic RMS tumors as well as in human and primary mouse RMS cultures, exhibiting a broad subcellular localization, ranging from nuclei and cytosol to plasma membrane. In particular, the coexpression and plasma membrane interaction between Cavin-1 and Cav-1 characterized the proliferation of human and mouse RMS cell cultures, while a downregulation of their expression levels was observed during the myogenic differentiation. Knockdown of Cavin-1 or Cav-1 in the human RD and RH30 cells led to impairment of cell proliferation and migration. Moreover, loss of Cavin-1 in RD cells impaired the anchorage-independent cell growth in soft agar. While the loss of Cavin-1 did not affect the Cav-1 protein levels in RMS cells, Cav-1 overexpression and knockdown triggered a rise or depletion of Cavin-1 protein levels in RD cells, respectively, in turn reflecting on increased or decreased cell proliferation, migration and anchorage-independent cell growth. Collectively, these data indicate that the interaction between Cavin-1 and Cav-1 underlies the cell growth and migration in myogenic tumors.
UR - http://www.scopus.com/inward/record.url?scp=84930021783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930021783&partnerID=8YFLogxK
U2 - 10.1038/labinvest.2015.45
DO - 10.1038/labinvest.2015.45
M3 - Article
C2 - 25822667
AN - SCOPUS:84930021783
SN - 0023-6837
VL - 95
SP - 585
EP - 602
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 6
ER -